- Home
- IMOS vs CLDX Comparison
IMOS vs CLDX Comparison
Compare IMOS & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMOS | CLDX |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2007 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IMOS | CLDX |
|---|---|---|
| Price | $64.29 | $37.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $46.60 |
| AVG Volume (30 Days) | 93.9K | ★ 1.1M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $21.75 | $111.39 |
| Revenue Next Year | $4.21 | $235.85 |
| P/E Ratio | $158.35 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $15.06 | $19.72 |
| 52 Week High | $72.91 | $37.54 |
Technical Indicators
Market Signals| Indicator | IMOS | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 74.39 |
| Support Level | $55.12 | $28.51 |
| Resistance Level | $71.95 | N/A |
| Average True Range (ATR) | 3.02 | 1.47 |
| MACD | -0.54 | 0.71 |
| Stochastic Oscillator | 51.82 | 81.78 |
Price Performance
Historical ComparisonAbout IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.